主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TNGX
#1968
Tango Therapeutics, Inc.
11.1
4
+0.81%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.81%
每月变动
-7.32%
6个月变化
+60.75%
年变化
+413.36%
前一天收盘价
11.0
5
Open
11.1
4
Bid
Ask
Low
11.1
4
High
11.1
4
交易量
136
市场
股票
医疗保健
TNGX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
107.42 M
108.11 M
108.39 M
111.26 M
134.59 M
—
Valuation ratios
Enterprise value
773.97 M
264.52 M
90.07 M
530.38 M
1.07 B
1.96 B
Price to earnings ratio
-6.64
-2.6
-1.14
-3.91
-9.23
-16.88
Price to sales ratio
18.89
8.02
3.63
23.03
14.68
49.37
Price to cash flow ratio
6.6
2.57
1.11
3.79
6.43
13.89
Price to book ratio
0.81
1.69
0.18
0.77
1.42
4.06
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.12
0.15
0.16
0.08
0.5
Return on equity %
0.13
0.19
0.24
0.29
0.1
0.82
Return on invested capital %
159.12
215.29
222.29
211.92
85.24
734.75
Gross margin %
100
100
100
100
100
400
Operating margin %
283.26
993.93
788.76
1 287.87
26.15
3 096.7
EBITDA margin %
—
—
—
—
—
—
Net margin %
251.29
915.21
739.54
1 221.41
29.52
2 905.68
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8
6.98
6.26
4.75
8.88
26.87
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.01
0.02
0.01
0.24
0.28
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.31
0.34
0.38
0.33
0.26
1.31
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
4.92
2.36
1.96
1.64
1.3
7.26
Net current asset value per share
2.77
2.44
2.04
1.72
1.39
7.59
Tangible book value per share
2.11
1.83
1.51
1.22
1.36
5.92
Working capital per share
2.43
2.09
1.71
1.36
1.23
6.39
Book value per share
2.11
1.83
1.51
1.22
1.36
5.92
新闻
Stifel重申Tango Therapeutics股票评级为买入
Stifel reiterates Tango Therapeutics stock rating at Buy
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
Tango Therapeutics股价触及52周高点13.5美元
Tango Therapeutics stock hits 52-week high at 13.5 USD
Mizuho首次覆盖Tango Therapeutics股票,给予跑赢大盘评级
Mizuho initiates Tango Therapeutics stock with outperform rating
Tango Therapeutics股价触及52周高点13.47美元
Tango Therapeutics stock hits 52-week high at $13.47
Tango Therapeutics首席财务官出售价值$126,530的TNGX股票
Tango Therapeutics CFO sells $126,530 in TNGX stock
Tango Therapeutics董事Weber Barbara出售价值37.4万美元TNGX股票